- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
49
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
49 companies
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩26,350.00
7D
1.5%
1Y
18.7%
Bonesupport Holding
Market Cap: SEK 13.7b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 202.00
7D
-2.1%
1Y
-41.8%
PharmaResearch
Market Cap: ₩4.8t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩460,000.00
7D
-7.2%
1Y
121.7%
Daiichi Sankyo Company
Market Cap: JP¥6.4t
Manufactures and sells pharmaceutical products in Japan, the United States, Europe, and internationally.
4568
JP¥3,481.00
7D
5.3%
1Y
-22.1%
Zhejiang Jolly PharmaceuticalLTD
Market Cap: CN¥11.9b
Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.
300181
CN¥17.21
7D
-2.5%
1Y
6.7%
Sawai Group Holdings
Market Cap: JP¥217.3b
Together with subsidiaries, engages in the research and development, manufacture, and marketing of generic pharmaceuticals.
4887
JP¥1,882.50
7D
-0.5%
1Y
-1.0%
AbbVie
Market Cap: US$410.7b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$232.36
7D
6.2%
1Y
39.7%
Rhythm Pharmaceuticals
Market Cap: US$6.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
RYTM
US$99.41
7D
1.8%
1Y
69.9%
Protagonist Therapeutics
Market Cap: US$5.3b
A biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases.
PTGX
US$84.61
7D
1.7%
1Y
109.5%
Telix Pharmaceuticals
Market Cap: AU$4.8b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$14.20
7D
-7.3%
1Y
-37.7%
NewAmsterdam Pharma
Market Cap: US$4.3b
A late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease.
NAMS
US$38.35
7D
-1.6%
1Y
55.5%
Hypera
Market Cap: R$16.2b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$25.61
7D
2.3%
1Y
23.7%
Immutep
Market Cap: AU$412.1m
A biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia.
IMM
AU$0.28
7D
9.8%
1Y
-11.1%
Neurocrine Biosciences
Market Cap: US$14.4b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$144.86
7D
-3.4%
1Y
23.2%
Exact Sciences
Market Cap: US$12.7b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$67.03
7D
0.7%
1Y
35.3%
Akeso
Market Cap: HK$107.0b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$116.20
7D
1.0%
1Y
81.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.30
7D
2.6%
1Y
-6.3%
Consun Pharmaceutical Group
Market Cap: HK$12.5b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$14.83
7D
-1.3%
1Y
74.5%
Shanghai OPM Biosciences
Market Cap: CN¥6.5b
Provides cell culture media and CDMO services in China and internationally.
688293
CN¥56.88
7D
-7.4%
1Y
35.9%
BioGaia
Market Cap: SEK 10.5b
A healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
BIOG B
SEK 103.30
7D
3.3%
1Y
-0.6%
Camurus
Market Cap: SEK 38.4b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 622.00
7D
-0.4%
1Y
13.9%
Sandoz Group
Market Cap: CHF 23.6b
Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.
SDZ
CHF 54.92
7D
2.0%
1Y
38.1%
Aroa Biosurgery
Market Cap: AU$236.3m
Develops, manufactures, and sells medical devices for wound and soft tissue repair using extracellular matrix (ECM) technology in the United States and internationally.
ARX
AU$0.69
7D
-12.2%
1Y
8.7%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$101.4b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$435.00
7D
5.2%
1Y
182.5%
Galderma Group
Market Cap: CHF 35.5b
Operates as a dermatology company worldwide.
GALD
CHF 146.40
7D
-0.6%
1Y
71.9%
InnoCare Pharma
Market Cap: HK$28.4b
A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.
9969
HK$14.79
7D
3.2%
1Y
130.7%
Vitrolife
Market Cap: SEK 19.4b
Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.
VITR
SEK 143.00
7D
2.8%
1Y
-33.2%
Ligand Pharmaceuticals
Market Cap: US$4.0b
A biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide.
LGND
US$200.86
7D
-4.0%
1Y
79.9%
Avadel Pharmaceuticals
Market Cap: US$2.3b
Operates as a biopharmaceutical company in the United States.
AVDL
US$23.56
7D
26.0%
1Y
119.9%
SK Biopharmaceuticals
Market Cap: ₩10.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩130,300.00
7D
9.0%
1Y
28.8%
Alnylam Pharmaceuticals
Market Cap: US$59.3b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$449.16
7D
1.7%
1Y
93.4%
Beijing Aosaikang Pharmaceutical
Market Cap: CN¥17.3b
Beijing Aosaikang Pharmaceutical Co., Ltd.
002755
CN¥18.59
7D
-1.1%
1Y
47.0%
Simcere Pharmaceutical Group
Market Cap: HK$35.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$13.78
7D
7.0%
1Y
101.2%
RemeGen
Market Cap: HK$51.8b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$84.65
7D
0.6%
1Y
431.7%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.9b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€52.25
7D
3.8%
1Y
4.5%
SKAN Group
Market Cap: CHF 1.1b
Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.
SKAN
CHF 47.45
7D
-2.6%
1Y
-33.2%